View drug registration information details.
Items | Registration information |
ID | 1245 |
No | 1245 |
Brand Name | CIPRULZ DRY SUSPENSION 125MG/5 ML |
Ingredients | CIPROFLOXACIN AS (HCL) 125 MG/5ML |
Dosage Form | POWDER FOR SUSPENSION |
Primary Packaging | Bottle |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | 60ML/BOTTLE/BOX |
Dispensing Category | Prescription only |
ATC Classification | J03CB03 |
Pharmaceutical Class | ANTIBACTERIA |
Indications | LOWER RESPIRATORY TRACT INFECTION DUE TO GRAM-NEGATIVE BACTERIA, CHRONIC SUPPURATIVE OTITIS MEDIA, URINARY TRACT INFECTION, GENITAL TRACT INFECTION,INTRA-ABDOMINAL INFECTION, INFECTION OF THE SKIN AND SOFT TISSUE… |
Contraindications | HYPERSENSITIVITY, CONCOMITANT ADMINISTRATION OF CIPROFLOXACIN AND TIZANIDINE |
Side Effects | NAUSEA, DIARRHEA, DECREASED APPETITE, HEADACHE, DIZZINESS, SLEEP DISORDERS, TASTE DISORDERS |
Unit Price | 0.70$ |
EDL |
Yes |
Description | OFF WHITE GRANULAR POWDER, OFF WHITE COLORED VISCOUS SUSPENSION HAVING BANANA FLAVOR, VISUALLY FREE FROM FOREIGN PARTICLES AFTER RECONSTITUTION. |
Note | |
License Owner | KONGCHAI-LAO PHARMA SOLE CO.,LTD |
Manufacturer | FOCUS & RULZ PHARMACEUTICALS (PVT) LTD |
Country | PAKISTAN |
Import Registration No | 68892 |
Import Registration Date | 2011-03-26 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-06-08 |
FDD Registration No | 06 I 4739/19 |
FDD Registration Date | 2022-09-26 |
Expiry Date | 2025-09-25 |
Back to drug list
|